CRISPR Reverses Chemo Resistance in Lung Cancer
CRISPR technology reverses chemotherapy resistance in lung cancer by disabling the NRF2 gene. This improves drug sensitivity and slows tumor growth, offering a novel strategy for resistant cancers.
Retron Gene Editing: Revolutionizing Treatment for Cystic Fibrosis & Genetic Diseases
Researchers enhance gene editing using retrons to efficiently replace entire genes, targeting multiple mutations in diseases like cystic fibrosis. This innovative approach offers broader, more affordable gene therapies.